ACOG practice bulletin No. 101: Ultrasonography in pregnancy

Obstetrics and Gynecology

Volumn 113, Issue 2 PART 1, 2009, Pages 451-461

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

AMNIOCENTESIS; AMNION FLUID; DOPPLER FLOWMETRY; ECHOGRAPHY; ECTOPIC PREGNANCY; FETUS DEATH; FETUS ECHOGRAPHY; FETUS GROWTH; FETUS HEART; FETUS MONITORING; FIRST TRIMESTER PREGNANCY; INFECTION CONTROL; INSTRUMENT STERILIZATION; PATIENT SAFETY; PHYSICIAN ATTITUDE; PREGNANCY; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; THREE DIMENSIONAL IMAGING; ARTICLE; CONGENITAL DISORDER; FEMALE; HUMAN; PRACTICE GUIDELINE; PREGNANCY COMPLICATION;

CONGENITAL ABNORMALITIES; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, FIRST; ULTRASONOGRAPHY, PRENATAL;

EID: 60549084017     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e31819930b0     Document Type: Review

References (44)

1. Goncalves LF, Lee W, Espinoza J, Romero R. Three- and 4-dimensional ultrasound in obstetric practice: does it help? J Ultrasound Med 2005;24:1599-624. (Level III)
2. Abuhamad AZ, Benacerraf BR, Woletz P, Burke BL. The accreditation of ultrasound practices: impact on compliance with minimum performance guidelines. J Ultrasound Med 2004;23:1023-9. (Level II-3)
3. Abramowicz JS, Fowlkes JB, Skelly AC, Stratmeyer ME, Ziskin MC. Conclusions regarding epidemiology for obstetric ultrasound. J Ultrasound Med 2008;27:637-44. (Level III)
4. American Institute of Ultrasound in Medicine. Medical ultrasound safety. Laurel (MD): AIUM; 1994; reapproved 2002. (Level III)
5. Stark CR, Orleans M, Haverkamp AD, Murphy J. Short-and long-term risks after exposure to diagnostic ultrasound in utero. Obstet Gynecol 1984;63:194-200. (Level II-2)
6. Lyons EA, Dyke C, Toms M, Cheang M. In utero exposure to diagnostic ultrasound: a 6-year follow-up. Radiology 1988;166:687-90. (Level II-2)
7. American Institute of Ultrasound in Medicine. Prudent Use. Laurel (MD): AIUM; 1999; reapproved 2005. (Level III)
8. Rados C. FDA cautions against ultrasound 'keepsake' images. FDA Consum 2004;38:12-6. (Level III)
9. American Institute of Ultrasound in Medicine. Guidelines for cleaning and preparing endocavitary ultrasound transducers between patients. Laurel (MD): AIUM; 2000. (Level III)
10. Centers for Disease Control and Prevention. Sterilization or disinfection of medical devices. Atlanta (GA): CDC; 2002. Available at: http://www.cdc.gov/ ncidod/dhqp/ bp-sterilization-medDevices.html. Retrieved June 9, 2008. (Level III)
11. Food and Drug Administration (US). FDA-cleared sterilants and high level disinfectants with general claims for processing reusable medical and dental devices -September 28, 2006. Rockville (MD): FDA; 2006. Available at: http://www.fda.gov/cdrh/ode/germlab.html. Retrieved June 9, 2008. (Level III)
12. Long G, Sprigg A. A comparative study of routine versus selective fetal anomaly ultrasound scanning. J Med Screen 1998;5:6-10. (Level III)
13. Ewigman BG, Crane JP, Frigoletto FD, LeFevre ML, Bain RP, McNellis D. Effect of prenatal ultrasound screening on perinatal outcome. RADIUS Study Group. N Engl J Med 1993;329:821-7. (Level I)
14. Saari-Kemppainen A, Karjalainen O, Ylostalo P, Heinonen OP. Fetal anomalies in a controlled one-stage ultrasound screening trial. A report from the Helsinki Ultrasound Trial. J Perinat Med 1994;22:279-89. (Level I)
15. Grandjean H, Larroque D, Levi S. The performance of routine ultrasonographic screening of pregnancies in the Eurofetus Study. Am J Obstet Gynecol 1999;181:446-54. (Level II-2)
16. Levi S. Ultrasound in prenatal diagnosis: polemics around routine ultrasound screening for second trimester fetal malformations. Prenat Diagn 2002;22:285-95. (Level III)
17. Crane JP, LeFevre ML, Winborn RC, Evans JK, Ewigman BG, Bain RP, et al. A randomized trial of prenatal ultrasonographic screening: impact on the detection, management, and outcome of anomalous fetuses. The RADIUS Study Group. Am J Obstet Gynecol 1994;171:392-9. (Level I)
18. Grandjean H, Larroque D, Levi S. Sensitivity of routine ultrasound screening of pregnancies in the Eurofetus database. The Eurofetus Team. Ann N Y Acad Sci 1998; 847:118-24. (Level II-3)
19. Eik-Nes SH, Salvesen KA, Okland O, Vatten LJ. Routine ultrasound fetal examination in pregnancy: the 'Alesund' randomized controlled trial. Ultrasound Obstet Gynecol 2000;15:473-8. (Level I)
20. Woolf SH. The accuracy and effectiveness of routine population screening with mammography, prostate-specific antigen, and prenatal ultrasound: a review of published scientific evidence. Int J Technol Assess Health Care 2001;17:275-304. (Level III)
21. American College of Obstetricians and Gynecologists. Invasive Prenatal Testing for Aneuploidy. ACOG Practice Bulletin 88. Washington, DC: ACOG; 2007. (Level III)
22. Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, et al. First-trimester or second-trimester screening, or both, for Down's syndrome. First- and Second-Trimester Evaluation of Risk (FASTER) Research Consortium. N Engl J Med 2005;353:2001-11. (Level II-1)
23. Spong C Y. Prediction and prevention of recurrent spontaneous preterm birth. Obstet Gynecol 2007;110:405-15. (Level III)
24. Iams JD, Goldenberg RL, Mercer BM, Moawad AH, Meis PJ, Das AF, et al. The preterm prediction study: can lowrisk women destined for spontaneous preterm birth be identified? National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 2001;184:652-5. (Level II-3)
25. Conoscenti G, Meir YJ, D'Ottavio G, Rustico MA, Pinzano R, Fischer-Tamaro L, et al. Does cervical length at 13-15 weeks' gestation predict preterm delivery in an unselected population? Ultrasound Obstet Gynecol 2003;21:128-34. (Level II-2)
26. Nyberg DA, Mack LA, Laing FC, Patten RM. Distinguishing normal from abnormal gestational sac growth in early pregnancy. J Ultrasound Med 1987;6:23-7. (Level II-3)
27. Wisser J, Dirschedl P, Krone S. Estimation of gestational age by transvaginal sonographic measurement of greatest embryonic length in dated human embryos. Ultrasound Obstet Gynecol 1994;4:457-62. (Level III)
28. Chervenak FA, Skupski DW, Romero R, Myers MK, Smith-Levitin M, Rosenwaks Z, et al. How accurate is fetal biometry in the assessment of fetal age? Am J Obstet Gynecol 1998;178:678-87. (Level II-3)
29. Stebbins B, Jaffe R. Fetal biometry and gestational age estimation. In: Jaffe R, Bui TH, editors. Textbook of fetal ultrasound. New York (NY): Parthenon Publishing; 1999. p. 47-57. (Level III)
30. Pierce BT, Hancock EG, Kovac CM, Napolitano PG, Hume RF Jr, Calhoun BC. Influence of gestational age and maternal height on fetal femur length calculations. Obstet Gynecol 2001;97:742-6. (Level II-3)
31. Goldstein RB, Filly RA. Sonographic estimation of amniotic fluid volume. Subjective assessment versus pocket measurements. J Ultrasound Med 1988;7:363-9. (Level III)
32. Baron C, Morgan MA, Garite TJ. The impact of amniotic fluid volume assessed intrapartum on perinatal outcome. Am J Obstet Gynecol 1995;173:167-74. (Level II-3)
33. Chauhan SP, Doherty DD, Magann EF, Cahanding F, Moreno F, Klausen JH. Amniotic fluid index vs single deepest pocket technique during modified biophysical profile: a randomized clinical trial. Am J Obstet Gynecol 2004;191:661-7; discussion 667-8. (Level I)
34. Ott WJ. Reevaluation of the relationship between amniotic fluid volume and perinatal outcome. Am J Obstet Gynecol 2005;192:1803-9; discussion 1809. (Level II-2)
35. Magann EF, Chauhan SP, Doherty DA, Lutgendorf MA, Magann MI, Morrison JC. A review of idiopathic hydramnios and pregnancy outcomes. Obstet Gynecol Surv 2007;62:795-802. (Level III)
36. Smith-Bindman R, Hosmer W, Feldstein VA, Deeks JJ, Goldberg JD. Second-trimester ultrasound to detect fetuses with Down syndrome: a meta-analysis. JAMA 2001;285:1044-55. (Level III)
37. Vintzileos AM, Campbell WA, Rodis JF, Guzman ER, Smulian JC, Knuppel RA. The use of second-trimester genetic sonogram in guiding clinical management of patients at increased risk for fetal trisomy 21. Obstet Gynecol 1996;87:948-52. (Level III)
38. Bromley B, Benacerraf BR. The genetic sonogram scoring index. Semin Perinatol 2003;27:124-9. (Level III)
39. Bahado-Singh RO, Oz UA, Mendilcioglu I, Mahoney MJ. The mid-trimester genetic sonogram. Semin Perinatol 2005;29:209-14. (Level III)
40. Yeo L, Vintzileos AM. The use of genetic sonography to reduce the need for amniocentesis in women at high-risk for Down syndrome. Semin Perinatol 2003;27:152-9. (Level III)
41. Hadlock FP, Deter RL, Harrist RB, Park SK. Estimating fetal age: computer-assisted analysis of multiple fetal growth parameters. Radiology 1984;152:497-501. (Level II-3)
42. Shepard MJ, Richards VA, Berkowitz RL, Warsof SL, Hobbins JC. An evaluation of two equations for predicting fetal weight by ultrasound. Am J Obstet Gynecol 1982; 142:47-54. (Level III)
43. American College of Obstetricians and Gynecologists. Intrauterine Growth Restriction. ACOG Practice Bulletin 12. Washington, DC: ACOG; 2000. (Level III)
44. American College of Obstetricians and Gynecologists. Fetal macrosomia. ACOG Practice Bulletin 22. Washington, DC: ACOG; 2000. (Level III)